Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer

Overview of attention for article published in PLOS ONE, May 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 90 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

PHARMACEUTICAL COMBINATION COMPRISING A CIP2A SILENCING AGENT FOR USE IN THE TREATMENT OF…

Application EP-3311815-A1

European Patent Office

PHARMACEUTICAL COMBINATION COMPRISING A CIP2A SILENCING AGENT FOR USE IN THE TREATMENT OF…

Application WO-2013034806-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.